Skandinaviska Enskilda Banken (SEB)
ELV icon

Skandinaviska Enskilda Banken (SEB)’s Elevance Health ELV Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-45,744
Closed -$16M – 340
2025
Q4 		$16M Sell
45,744
-1,655
-3% -$559K 0.06% 212
2025
Q3 		$15.3M Sell
47,399
-15,128
-24% -$4.71M 0.06% 217
2025
Q2 		$24.3M Buy
62,527
+12,154
+24% +$4.89M 0.11% 159
2025
Q1 		$21.9M Sell
50,373
-13,454
-21% -$5.4M 0.11% 158
2024
Q4 		$23.5M Sell
63,827
-13,390
-17% -$5.6M 0.11% 158
2024
Q3 		$40.2M Sell
77,217
-27,681
-26% -$14.8M 0.19% 98
2024
Q2 		$56.8M Sell
104,898
-65,902
-39% -$34.8M 0.27% 66
2024
Q1 		$88.6M Sell
170,800
-16,365
-9% -$8.14M 0.43% 42
2023
Q4 		$88.3M Sell
187,165
-4,876
-3% -$2.25M 0.51% 34
2023
Q3 		$83.6M Sell
192,041
-3,003
-2% -$1.36M 0.55% 33
2023
Q2 		$86.7M Buy
195,044
+10,607
+6% +$4.89M 0.57% 30
2023
Q1 		$84.8M Buy
184,437
+24,314
+15% +$11.6M 0.59% 31
2022
Q4 		$82.1M Buy
160,123
+16,554
+12% +$8.41M 0.62% 31
2022
Q3 		$65.2M Sell
143,569
-51,369
-26% -$24.6M 0.5% 47
2022
Q2 		$94.1M Buy
194,938
+40,902
+27% +$20.2M 0.69% 24
2022
Q1 		$75.7M Buy
154,036
+23,844
+18% +$10.9M 0.44% 48
2021
Q4 		$60.8M Sell
130,192
-5,927
-4% -$2.49M 0.31% 69
2021
Q3 		$50.7M Buy
136,119
+27,592
+25% +$10.5M 0.28% 84
2021
Q2 		$41.4M Buy
108,527
+20,081
+23% +$7.67M 0.25% 88
2021
Q1 		$31.7M Buy
88,446
+26,336
+42% +$8.47M 0.21% 109
2020
Q4 		$19.9M Buy
62,110
+7,737
+14% +$2.37M 0.14% 147
2020
Q3 		$14.6M Buy
54,373
+8,000
+17% +$2.15M 0.11% 180
2020
Q2 		$12.2M Sell
46,373
-1,486
-3% -$396K 0.1% 194
2020
Q1 		$10.9M Sell
47,859
-6,604
-12% -$1.8M 0.11% 172
2019
Q4 		$16.4M Buy
54,463
+37
+0.1% +$10.2K 0.13% 155
2019
Q3 		$13.1M Buy
54,426
+5,239
+11% +$1.44M 0.11% 166
2019
Q2 		$13.9M Buy
49,187
+7,240
+17% +$1.98M 0.12% 164
2019
Q1 		$12M Buy
41,947
+1,310
+3% +$379K 0.11% 166
2018
Q4 		$10.7M Sell
40,637
-2,296
-5% -$631K 0.1% 166
2018
Q3 		$11.8M Sell
42,933
-2,746
-6% -$713K 0.09% 167
2018
Q2 		$10.9M Buy
45,679
+15,389
+51% +$3.56M 0.09% 158
2018
Q1 		$6.66M Sell
30,290
-17,339
-36% -$4.07M 0.06% 190
2017
Q4 		$10.7M Buy
47,629
+1,199
+3% +$255K 0.09% 177
2017
Q3 		$8.82M Buy
46,430
+2,000
+5% +$381K 0.08% 205
2017
Q2 		$8.36M Sell
44,430
-1,965
-4% -$353K 0.08% 220
2017
Q1 		$7.67M Buy
+46,395
New +$7.38M 0.08% 214
2016
Q4 		– Sell
-46,014
Closed -$5.77M – 699
2016
Q3 		$5.77M Sell
46,014
-99,600
-68% -$12.9M 0.06% 223
2016
Q2 		$19.1M Buy
145,614
+1,200
+0.8% +$164K 0.21% 86
2016
Q1 		$20.1M Buy
+144,414
New +$19.3M 0.23% 86

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s ELV Position: Q1 2026 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 45,744 shares — an estimated $16M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in ELV in Q1 2016 and held it in 39 quarters. The position peaked at $94.1M in Q2 2022. 1,468 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 45,744 Elevance Health shares in Q1 2026, an estimated $16M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Elevance Health in Q1 2016 and held it in 39 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Elevance Health position peaked at $94.1M in Q2 2022.
  • 1,468 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2026, filed 15 May 2026.